Ameya Umesh Borwankar

Title: Ameya Umesh Borwankar: Innovator in Antibody Manufacturing

Introduction

Ameya Umesh Borwankar is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of antibody manufacturing, holding 2 patents that address critical challenges in the industry. His work is characterized by innovative methods that enhance the efficiency and quality of antibody production.

Latest Patents

One of his latest patents is a method of controlling the pink color generated during antibody manufacturing. This invention focuses on preventing the generation of pink color by either inhibiting the reduction of antibodies during manufacturing and harvest or by preventing the conversion of cyanocobalamin (CN-Cbl) to hydroxocobalamin (HO-Cbl). The method includes replacing white light in the cell culture media preparation and storage areas with red light to inhibit this conversion. Additionally, the addition of peroxides to the clarified bulk at harvest helps to inhibit the reduction of antibody disulfide bonds. Another significant patent involves a novel flush method using a recovery flush technique that minimizes yield losses due to inadequate flushing and prevents or reduces dilution of a target protein during a recovery flush.

Career Highlights

Ameya Umesh Borwankar is currently employed at Bristol-Myers Squibb Company, where he continues to innovate in the field of biopharmaceuticals. His work has been instrumental in improving manufacturing processes and ensuring the quality of therapeutic antibodies.

Collaborations

He collaborates with talented coworkers, including Abhiram Arunkumar and Nripen Singh, who contribute to the advancement of their projects and innovations.

Conclusion

Ameya Umesh Borwankar's contributions to antibody manufacturing through his innovative patents demonstrate his commitment to enhancing biopharmaceutical processes. His work not only addresses current challenges but also paves the way for future advancements in the field.